logo

For the Inventor, By the Inventor

Kettleby, Canada

Rachelle MacSweeney

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Kettleby, CA (2014 - 2015)
  • King, CA (2016)

Company Filing History:

goldMedal5 out of 5 
 
Pivotal Therapeutics, Inc.
 patents

Years Active: 2014-2016

Loading Chart...
5 patents (USPTO):Explore Patents
1. 9248138 - Process and composition for stabilization of vulnerable plaque utilizing a combination of a statin and omega 3 fatty acids (2016-02-02),
2. 9119826 - Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels (2015-09-01),
3. 8952000 - Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events (2015-02-10),
4. 8951514 - Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels (2015-02-10),
5. 8715648 - Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics (2014-05-06),

Title: Innovations by Rachelle MacSweeney: Pioneering Cardiovascular Treatments

Introduction

Rachelle MacSweeney, an accomplished inventor based in Kettleby, CA, has made significant strides in the field of cardiovascular health through her innovative solutions. With five patents to her name, she continues to address critical health issues related to lipid management and cardiovascular disease.

Latest Patents

Among Rachelle's latest contributions is her patented process and composition for stabilizing vulnerable plaque, which combines statins with omega-3 fatty acids. This groundbreaking method aims to enhance treatment effectiveness for individuals at risk of cardiovascular complications. Her innovative approach uses a precise formulation of omega-3 fatty acids, including Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA), and Docosahexaenoic acid (DHA), designed to stabilize plaque while addressing omega-3 deficiencies.

Another recent patent revolves around a diagnostic kit aimed at managing cardiovascular patients suffering from deficiencies in blood levels of EPA and DHA. This kit includes a diagnostic assay that helps determine levels of these critical fatty acids in blood and provides a prescription medical food formulation aimed at improving patients’ health outcomes.

Career Highlights

Rachelle is currently affiliated with Pivotal Therapeutics, Inc., where she utilizes her expertise to advance therapeutic solutions for cardiovascular diseases. Her visionary approach and commitment to research have enabled her to develop treatments that can potentially transform the lives of patients dealing with heart ailments.

Collaborations

Throughout her career, Rachelle has collaborated with notable professionals in the field, including her coworkers George Jackowski and Nisar Ahmad Shaikh. These partnerships have fostered an environment of innovation and facilitated the development of her patented solutions.

Conclusion

Rachelle MacSweeney’s contributions to the field of cardiovascular health illustrate her dedication to innovation and patient care. With her ongoing work at Pivotal Therapeutics, Inc. and a portfolio of patents focused on vital medical solutions, she continues to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…